arrow
K

Kay See Tan

Memorial Sloan Kettering Cancer Center
H指数:43
被引数:7,288

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Utilization of invasive mediastinal nodal staging and prevalence of occult nodal disease in patients with synchronous primary lung cancers

利用侵入性纵隔淋巴结分期和隐匿性淋巴结疾病在同时性原发性肺癌患者中的患病率

2026-04-190
PRE
Surgical Outcomes Using Three-Dimensional Image Simulation for Segmentectomy Planning in Patients with Stage IA1-2 Non-Small Cell Lung Cancer

使用三维图像模拟进行段切除术规划在IA1-2期非小细胞肺癌患者中的手术结果

2025-12-050
PRE
Resectable non- small cell lung cancer in women: A disease-specific entity?

可切除非小细胞肺癌在女性中:一种疾病特异实体?

2025-12-010
OAAI
Lobectomy Improves Disease-Free Survival Over Sublobar Resection for High-Risk Stage IA Non-Small Cell Lung Cancer

肺叶切除术相较于亚肺叶切除术能改善高风险IA期非小细胞肺癌的无病生存期。

2025-08-290
PRE
Robotic-assisted bronchoscopy for histopathologic subtyping of primary lung adenocarcinoma

机器人辅助支气管镜检查用于原发性肺腺癌的病理亚型分类

2025-07-280
PRE
Determinants of successful minimally invasive surgery for resectable non-small cell lung cancer after neoadjuvant therapy

新辅助治疗后可切除非小细胞肺癌成功实施微创手术的影响因素

2025-03-010
PRE
Angiotensin receptor/neprilysin inhibitor (ARNI) utilisation and prescribing patterns in Sarawak
2024-12-010
PRE
Impact of heart failure clinic on optimization of guideline- directed medical therapy in management of heart failure with reduced ejection fraction: A multicentre study
2024-12-010
PRE
Review of clinical characteristic of heart failure in Sarawak
2024-12-010
PRE